| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | United States | 3 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Australia | 2 | |
| #5 | Canada | 2 | |
| #6 | China | 2 | |
| #7 | Japan | 2 | |
| #8 | Republic of Korea | 2 | |
| #9 | Brazil | 1 | |
| #10 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Guilford William J | 21 |
| #2 | Faulds Daryl H | 16 |
| #3 | Faulds Daryl | 5 |
| #4 | Seifert Wolfgang | 5 |
| #5 | Daryl H Faulds | 1 |
| #6 | William J Guilford | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2015109112A1 | Combination treatment of antibiotic and gpcr agonist for viral/bacterial co-infections | |
| CN105555276A | Beraprost isomer as agent for the treatment of viral infection | |
| AU2010306914A1 | Combination therapy treatment for viral infections | |
| EP2269611A2 | EP2 and EP4 agonists as agents for the treatment of influenza A viral infection |